Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Article
en En
| MEDLINE
| ID: mdl-30606884
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Quimioterapia Adyuvante
/
Neoplasias del Colon
/
Diabetes Mellitus Tipo 2
/
Fluorouracilo
/
Oxaliplatino
/
Hipoglucemiantes
/
Metformina
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2019
Tipo del documento:
Article